Gian María Fimia - Infectious Diseases

Author Information

Gian Maria Fimia is a prominent researcher affiliated with the National Institute for Infectious Diseases 'L. Spallanzani' in Rome, Italy, and the Department of Biological and Environmental Sciences and Technologies (DiSTeBA) at the University of Salento in Lecce, Italy. His work primarily focuses on the field of infectious diseases, with significant contributions to understanding disease mechanisms and potential therapeutic strategies.

Research Contributions

Gian Maria Fimia has made substantial contributions to the field of infectious diseases and related biological processes. His recent research includes studies on the modulation of insulin secretion, the effect of secreted proteins from ovarian tissues, and the interplay between SARS-CoV-2 infected airway epithelium and immune cells. He has also been involved in developing guidelines for autophagy assays and researching the role of autophagy in major human diseases. His work on SARS-CoV-2 specifically highlights the identification of host targets and potential pharmacological strategies for treatment.

Aliases

Gian Maria Fimia is known by several aliases, including Gian M Fimia, Gianmaria Fimia, G.m. Fimia, G. M. Fimia, and Gian María Fimia. These variations of his name are used across different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	27,676
h-index	61
Total Number of Papers	184

Publications:

Peroxiredoxin 6 Modulates Insulin Secretion and Beta Cell Death via a Mitochondrial Dynamic Network

DOI: 10.3389/fendo.2022.842575

Year: 2022

Analysis of Secreted Proteins from Prepubertal Ovarian Tissues Exposed In Vitro to Cisplatin and LH

DOI: 10.3390/cells11071208

Year: 2022

The interplay between SARS-CoV-2 infected airway epithelium and immune cells modulates regulatory/inflammatory signals

DOI: 10.1016/j.isci.2022.103854

Year: 2022

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

DOI: 10.1080/15548627.2020.1797280

Year: 2021

AMBRA1 regulates mitophagy by interacting with ATAD3A and promoting PINK1 stability.

DOI: 10.1080/15548627.2021.1997052

Year: 2021

Autophagy in major human diseases

DOI: 10.15252/embj.2021108863

Year: 2021

Rationale and Criteria for a COVID-19 Model Framework

DOI: 10.3390/v13071309

Year: 2021

Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection

DOI: 10.1016/j.antiviral.2021.105064

Year: 2021

Pharmacological Modulators of Autophagy as a Potential Strategy for the Treatment of COVID-19

DOI: 10.3390/ijms22084067

Year: 2021

Transglutaminase Type 2 regulates the Wnt/β-catenin pathway in vertebrates

DOI: 10.1038/s41419-021-03485-2

Year: 2021

How is Strep Throat Transmitted?

How does Dexamethasone work?

What Role Do International Organizations Play?

What Measures Can Be Taken to Prevent Transmission from Asymptomatic Carriers?

What Happens After the Biopsy?

How Are STIs Diagnosed?

What is a Pathogen?

What Could Be Causing Weight Loss?

What Are the Side Effects of Artemisinin?

Are There Any Risks Associated with Symptomatic Relief?

Partnered Content Networks

Relevant Topics